The efficacy of acupressure to prevent anti-tuberculosis drugs-induced adverse effects in pulmonary tuberculosis patients

Completed

• Conditions: Pulmonary tuberculosis; Infections and Infestations; Tuberculosis

• Registration Number: ISRCTN93554714
• Lead Sponsor: Taipei Veterans General Hospital

Brief Summary

1. 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30375013 (added 31/01/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-02
• Study Completion: 2016-06-28
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

Pulmonary tuberculosis patients aged 20 years old or over

Exclusion Criteria

Has cancer, severe liver or renal disease, extra-pulmonary TB, and consciousness unclear

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Adverse drug effects; the research assistant will collect the data from patients’ self-report, like the type, frequency and severity of adverse drug effects<br> 2. Physiological changes<br> 3. Patient’s adherence, using their medical charts<br> All outcomes will be measured at baseline, and every month until they complete their treatment<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Health-related quality of life, using the Short-Form-36 Health Survey<br> 2. Cure rate, using medical charts<br> All outcomes will be measured at baseline, and every month until they completed their treatment<br>